| Authors: |
Shelton RC; Department of Psychiatry and Behavioral Neurobiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Litman RE; Georgetown University Medical School, Washington, DC., Hassman H; Hassman Research Institute, Marlton, New Jersey., Walling DP; Collaborative Neuroscience Network Garden Grove, Garden Grove, California., Ros Montalbán S; Instituto Internacional de Neurociencias Aplicadas Barcelona, Barcelona, Spain., Salvà-Coll J; Hospital Universitari Son Espases, Servicio de Psiquiatría, UIB, IdISBa, Palma de Mallorca, Spain., Zajecka J; Psychiatric Medicine Associates, LLC, Skokie, Illinois., Sverdlov O; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Gomez-Mancilla B; Novartis Biomedical Research, Cambridge, Massachusetts.; Novartis Pharma AG, Basel, Switzerland.; McGill University, Montreal, Québec, Canada., Healy MP; Novartis Biomedical Research, Cambridge, Massachusetts.; Corresponding Author: Mark P. Healy, PhD, Global Discovery Chemistry, Novartis Biomedical Research, 22 Windsor St, Cambridge, MA 02478 (mark.healy@novartis.com)., Shanker YG; Novartis Biomedical Research, Cambridge, Massachusetts.; Beam Therapeutics, Cambridge, Massachusetts., Berkheimer M; Novartis Biomedical Research, Cambridge, Massachusetts., Faller T; Novartis Pharma AG, Basel, Switzerland., von Raison F; Novartis Pharma S.A.S., Rueil Malmaison, France., Serban C; Novartis Pharma AG, Basel, Switzerland., Cha JH; Novartis Biomedical Research, Cambridge, Massachusetts., Ghaemi SN; Novartis Biomedical Research, Cambridge, Massachusetts.; Tufts University School of Medicine, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts. |
